Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $132.69 | 0.79% | 164.70B |
Boeing BA | $221.30 | 2.67% | 174.45B |
| $61.00 | 0.05% | 27.75B | |
Walt Disney DIS | $101.31 | 1.72% | 179.47B |
Corteva CTVA | $81.69 | 1.04% | 54.84B |
| $57.38 | 1.44% | 117.17B | |
| $379.64 | 0.93% | 4.60T | |
Veeva Systems VEEV | $170.22 | 0.80% | 27.98B |
| $73.41 | 1.53% | 122.59B | |
TransUnion TRU | $69.05 | 2.10% | 13.31B |
U.S. Bancorp USB | $55.24 | 1.88% | 85.90B |
| $112.18 | 2.04% | 31.70B | |
| $290.76 | 1.52% | 73.41B | |
Allegion ALLE | $132.49 | 2.21% | 11.39B |
Kenvue KVUE | $17.15 | 1.61% | 32.93B |
| $82.67 | 0.28% | 15.99B | |
Pfizer PFE | $26.30 | 0.11% | 149.60B |
| $257.86 | 0.51% | 6.90B | |
Nike NKE | $43.09 | 2.95% | 63.81B |
| $70.09 | 1.02% | 17.90B | |
| $96.31 | 10.47% | 81.83B | |
Teradyne TER | $337.44 | 2.31% | 52.82B |
| $81.33 | 2.56% | 29.42B | |
| $20.50 | 1.11% | 6.11B | |
Adobe ADBE | $253.96 | 1.30% | 102.65B |
| $95.30 | 1.44% | 51.57B | |
MarketAxess MKTX | $154.89 | 1.32% | 5.45B |
| $363.37 | 0.77% | 14.31B | |
Brown Forman Inc BF-B | $24.66 | 3.48% | 11.31B |
Salesforce CRM | $185.48 | 0.90% | 151.73B |
Charles Schwab SCHW | $91.48 | 0.07% | 160.29B |
Emerson EMR | $135.46 | 1.45% | 76.13B |
Amazon AMZN | $272.05 | 1.35% | 2.93T |
| $1,573.30 | 0.64% | 77.30B | |
Autodesk ADSK | $247.54 | 1.31% | 52.23B |
| $298.35 | 0.90% | 66.44B | |
Amgen AMGN | $323.85 | 1.81% | 174.88B |
Otis Worldwide OTIS | $75.88 | 1.56% | 29.12B |
| $462.60 | 1.41% | 171.91B | |
Lam Research LRCX | $258.57 | 0.75% | 323.36B |
Masco MAS | $68.49 | 3.86% | 13.82B |
Mondelez MDLZ | $61.38 | 0.02% | 78.79B |
Honeywell HON | $209.59 | 1.37% | 132.81B |
| $567.00 | 0.20% | 80.53B | |
Equifax EFX | $172.24 | 0.93% | 20.78B |
IDEX IEX | $214.33 | 0.28% | 15.86B |
Microsoft MSFT | $413.62 | 0.14% | 3.07T |
Danaher DHR | $174.04 | 0.63% | 123.18B |
Merck MRK | $113.11 | 0.85% | 279.37B |
| $148.14 | 3.06% | 25.51B | |
| $300.18 | 0.17% | 21.21B | |
Apple AAPL | $276.83 | 1.22% | 4.07T |
